Contribution: Industrial Research Assistance Program – Contributions to Firms
Torus Biomedical Solutions Inc.
$49,600.00
Clinical Validation of the ConfirMap MVP
FY 2018-19 · 2019-02-01
Summary
The proposed project concerns the clinical validation of the firm's initial medical-device solution. The principal objective of this effort will be to confirm the efficacy of the solution's underlying technology within a true production environment and with a statistically significant number of patients.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Unity|Unity, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
812355303
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-02-01 | 2018-19 | $49,600.00 |
| 1 | 2019-02-01 | 2018-19 | $49,600.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Additional Information (French)
La date de fin du présent accord a été changé de 92 jours. Cet accord a été modifié 1 fois
Agreement End Date
2019-10-31
Agreement Number
920123
Agreement Start Date
2019-02-01
Agreement Title
Clinical Validation of the ConfirMap MVP
Agreement Title (French)
Validation clinique du PPPV ConfirMap
Agreement Type
Contribution
Agreement Value
$49,600.00
Amendment Date
2019-05-29
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The proposed project concerns the clinical validation of the firm's initial medical-device solution. The principal objective of this effort will be to confirm the efficacy of the solution's underlying technology within a true production environment and with a statistically significant number of patients.
Description (French)
Le projet proposé concerne la validation clinique de la solution médicale initiale de l'entreprise. L'objectif principal de cet effort sera de confirmer l'efficacité de la technologie sous-jacente de la solution dans un véritable environnement de production et avec un nombre statistiquement significatif de patients.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
812355303
Recipient City
Unity|Unity
Recipient Country
CA
Recipient Legal Name
Torus Biomedical Solutions Inc.
Recipient Postal Code
V6A 0A1
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q4-920123
